Sathgen Therapeutics LLC is a biotech company advancing promising small-molecule cancer therapies, with a current focus on oncology drug discovery and early clinical development. Sathgen Biotech operates as a division of Godavari Biorefineries Ltd., leveraging Godavari’s backing and state-of-the-art R&D infrastructure in Mumbai, where the company conducts cutting-edge anti-cancer drug screening using novel methods and drives its core research programs. Clinical development activities, including trials and key supporting work, have been executed in India in collaboration with experienced clinical and regulatory partners to generate credible, decision-ready data. Our lead program, MSP008-22, has completed Phase 1a, demonstrating strong safety and tolerability in healthy volunteers and in patients with advanced solid tumors, including triple-negative breast cancer, and is progressing into Phase 1/1b evaluation to further characterize safety, tolerability, and pharmacokinetics. To expand global partnering and development capabilities, we have recently launched our U.S. subsidiary based in Princeton, New Jersey, and we are actively seeking licensing, co-development, and strategic collaboration partners to accelerate clinical progress and broaden the impact of our pipeline.

SATHGEN THERAPEUTICS

Org chart

Teams

Offices

SATHGEN THERAPEUTICS

Org chart

Teams

Offices

Related companies